Lucid Diagnostics (LUCD) Cash from Operations (2020 - 2026)

Lucid Diagnostics (LUCD) has reported Cash from Operations for 7 consecutive years, with -$11.3 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Cash from Operations fell 7.11% year-over-year to -$11.3 million; the trailing twelve-month figure through Jun 2026 stood at -$46.9 million (down 8.89% YoY), and the FY2025 full-year result was -$46.5 million, down 5.35% from the prior year.
• Cash from Operations rose to -$11.3 million in Q2 2026 per LUCD's latest filing, from -$12.1 million in the prior quarter.
• Across five years, Cash from Operations topped out at -$4.3 million in Q4 2022 and bottomed at -$13.3 million in Q2 2022.
• Historically, Cash from Operations has averaged -$9.8 million across 5 years, with a median of -$10.4 million in 2024.
• The widest YoY moves for Cash from Operations: up 56.89% in 2022, down 479.99% in 2022.
• Over 5 years, Cash from Operations stood at -$4.3 million in 2022, then sank by 134.36% to -$10.0 million in 2023, then grew by 1.08% to -$9.9 million in 2024, then decreased by 27.58% to -$12.6 million in 2025, then gained by 10.28% to -$11.3 million in 2026.
• According to Business Quant data, Cash from Operations over the past three periods registered -$11.3 million, -$12.1 million, and -$12.6 million for Q2 2026, Q1 2026, and Q4 2025 respectively.